Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00065403 · ClinicalTrials.gov registry record · Phase 1
Acupuncture for Irritable Bowel Syndrome
A Phase 1 study of Irritable Bowel Syndrome, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT00065403: Completed Phase 1 study of Irritable Bowel Syndrome, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00065403 is a Phase 1 study of Irritable Bowel Syndrome that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 260 participants, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (87% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00065403, a Phase 1 study of Irritable Bowel Syndrome, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
Little is known about acupuncture's efficacy for Irritable Bowel Syndrome (IBS). This trial uses a manualized acupuncture treatment format that closely follows clinical practice and allows flexibility in designing individualized treatments. In addition, a second parallel qualitative study will follow a subgroup of patients throughout the trial to explore the relationships between patients' interpretations and understandings (what anthropologists call "meaning") of irritable bowel and their response to treatment. Cortisol levels (an important stress hormone) will also be assessed. This will be a 3-arm trial: Active acupuncture, placebo acupuncture, and wait list.
Conditions Studied
Interventions
- DEVICE Acupuncture
Study Locations (1)
Massachusetts
- Harvard Medical School - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2004-02 |
| Est. Completion | 2005-09 |
| Phase | Phase 1 |
What the finished NCT00065403 record still lists
NCT00065403 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (87% higher).
The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.
NCT00065403 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00065403 about?
NCT00065403 is a clinical study titled "Acupuncture for Irritable Bowel Syndrome". Little is known about acupuncture's efficacy for Irritable Bowel Syndrome (IBS). This trial uses a manualized acupuncture treatment format that closely follows clinical practice and allows flexibility in designing individualized treatments. In addition, a second parallel qualitative study will follo...
What is the current status of trial NCT00065403?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 260 participants. The study started on 2004-02. Estimated completion is 2005-09.
What conditions does trial NCT00065403 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome.
What interventions are being tested in trial NCT00065403?
The interventions under investigation include: Acupuncture (DEVICE).
Who is sponsoring clinical trial NCT00065403?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00065403 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00065403's enrollment target sits among peer trials
260 8th of 47 higher than 40 of 47 other Irritable Bowel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Irritable Bowel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
COMPLETED · Phase 1
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Psyllium in Pediatric IBS
RECRUITING · Phase 2
-
Mucosal and Microbiota Changes During Acute Campylobacteriosis
RECRUITING
-
GI Alpha-Gal Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia